Form D · Venture Capital Fund
Borealis Fund V - Veterinary Innovation, LP
Hanover, NH · CIK 0001877030
Offering snapshot reported Sep 20, 2022 · SEC filing
- Reported sold
- $33.6M Offering amount: $50M
- Investors reported
- 55 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 6, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
- Reported investors0 → 55
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 20, 2022 | Amendment | $33,590,000 | No comparison | 55 | SEC filing |
| Sep 21, 2021 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06b, 3C, 3C.1
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-414015
Source: Form D, filed Sep 20, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| N/A Borealis Capital Partners V, Llc | Executive |
| Philip Ferneau | Executive |
| Benjamin Shaw | Executive |
| Julia Stephanus | Executive |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:
10 Allen Street
Hanover, NH, 03755
Hanover, NH, 03755